URN | urn:agi-cas:53678-77-6 |
---|---|
Total Entities | 0 |
Connectivity | 711 |
Name | muramyl dipeptide |
Molecular Weight | 492.477580 |
XLogP | -3.700000 |
Pathway | NOD-like Receptors |
---|---|
Toll-like Receptor Independent Sterile Inflammation | |
Macrophage Function in Diabetes Mellitus Type 1 | |
Crohn's Disease | |
Paneth-Cell Function in Crohn's Disease | |
Macrophage Dysfunction | |
Dendritic Cell Dysfunction in Crohn's disease | |
Dendritic Cell Function in Ulcerative Colitis | |
Blau Syndrome | |
Model of PPARG signaling in psoriasis | |
Model of PPARG related pathways in psoriasis (short version) | |
1_Insufficient activation of immune response in the middle ear epithelium cells in otitis media | |
2_Paneth cell dysfunction in Crohn's disease | |
1_Defects in response to pathogens in the gut promotes inflammation in Crohn's disease | |
3_Autophagy dysfunction in Crohn's disease | |
2_Intestine epithelial cells drive immunological responses in ulcerative colitis |
MedScan ID | 1203017 |
---|
Alias | N(sup 2)-(N-(N-acetylmuramyl)-L-alanyl)-D-alpha-glutamine |
---|---|
EINECS 258-696-9 | |
N-acetylmuramyl-levo-alanyl-dextro-isoglutamine | |
BRN 4220745 | |
N-acetylmuramylalanyl-dextro-isoglutamine | |
N-acetylmuramyl-L-alanyl-D isoglutamine | |
N-Acetylmuramyl-L-alanyl-D-isoglutamine hydrate | |
4-[2-[2-[3-acetylamino-2,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxo-pentanoic acid | |
53678-77-6 | |
N-acetylmuramylalanyl-D-isoglutamine | |
N2-(N-(N-acetylmuramyl)-L-alanyl)-D-alpha-glutamine | |
Muramyl Dipeptide | |
N-acetyl muramyl-L-alanyl-D-isoglutamine | |
(+)-N2-(N-(N-acetylmuramyl)-L-alanyl)-D-alpha-Glutamine | |
4-[2-[2-[3-acetylamino-2,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxo-pentanoate | |
ac-muramyl-ala-d-glu-nh2 | |
N-(N-acetylmuramyl)-L-alanyl-D-alpha-Glutamine | |
Acetylmuramyl-alanyl-isoglutamine | |
N2-(N-(N-Acetylmuramoyl)-L-alanyl)-D-alpha-glutamine | |
(+)-N2-(N-(N-acetylmuramoyl)-L-alanyl)-D-alpha-Glutamine | |
N-(N-acetylmuramoyl)-L-alanyl-D-alpha-Glutamine | |
N(sup 2)-(N-(N-Acetylmuramoyl)-L-alanyl)-D-alpha-glutamine | |
D-alpha-Glutamine, N-(N-acetylmuramoyl)-L-alanyl- | |
Adjuvant Peptide | |
D-alpha-Glutamine, N2-(N-(N-acetylmuramoyl)-L-alanyl)- | |
D-alpha-Glutamine, N2-(N-(N-acetylmuramoyl)-L-alanyl)-, (+)- | |
D-alpha-Glutamine, N(sup 2)-(N-(N-acetylmuramoyl)-L-alanyl)- |
CAS ID | 53678-77-6 |
---|
Reaxys ID | 4220745 |
---|
InChIKey | MEJOVVKHFORGKW-HOMBLFBHSA-N |
---|---|
BSOQXXWZTUDTEL-IXJLSLDXSA-N |
Molecular Formula | C19H32N4O11 |
---|
PubChem SID | 135004313 |
---|---|
181651 |
PubChem CID | 91667728 |
---|---|
40846 |
XLogP-AA | -4.6 |
---|
IUPAC Name | (4R)-4-[[(2S)-2-[[(2R)-2-[(1R,2R,3R)-1-[(1R)-1-acetamido-2-keto-ethyl]-2,3,4-trihydroxy-butoxy]propanoyl]amino]propanoyl]amino]-5-amino-5-keto-valeric acid |
---|---|
(4R)-4-[[(2S)-2-[[(2R)-2-[(2R,5S)-3-acetamido-2,5-dihydroxy-6-methylol-tetrahydropyran-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-keto-valeric acid |
Rotatable Bond Count | 16 |
---|---|
12 |